Top Markets
Coin of the day
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Clasificación en acciones #30348
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Precio por acción
$0.93298493
Capitalización bursátil
$17.19M
Cambio (1 día)
-1.38%
Cambio (1 año)
-62.47%
País
JP
Comercio Perseus Proteomics Inc. (4882)

Categoría

Historial del precio de la acción de Perseus Proteomics Inc. (4882)
Precio más alto de cierre: $0.94 el 2026-08-01

Precio más bajo de cierre: $7.34 el 2021-06-01
Historial del precio de la acción de Perseus Proteomics Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -5.78%
2025 -60.94%
2024 -2.22%
2023 82.81%
2022 -26.01%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$1.23K 74.37%
US
$271.04 52.44%
US
$258.13 25.19%
US
$477.05 41.32%
CH
$135.49 59.53%
US